Summary. The profiles of hypoxanthine guanine phosphoribosyl transferase (HGPRT) and adenine phosphoribosyl transferase (APRT) activities were examined in normally fertilized human embryos developing at the normal rate in vitro between the 2\p=n-\4-cell stage on Day 2 and the blastocyst stage on Day 6 after insemination. The activities of both enzymes were assayed simultaneously in extracts of single embryos by measuring the rate of production of the reaction products, inosine monophosphate (IMP) and adenine monophosphate (AMP), separated by high-performance liquid chromatography (HPLC). The activity profiles of the two enzymes over this period showed marked differences. The activity of HGPRT, coded by the X chromosome, increased between Days 2 and 4 (P < 0\m=.\01) but declined sharply by Day 6 (P < 0\m=.\001), whereas autosome-coded APRT activity remained low between Days 2 and 5, but increased on Day 6 (P < 0\m=.\05). The profile ofHGPRT activity may reflect a combination of decreasing levels of maternal enzyme inherited from the oocyte and the initiation of embryonic gene expression followed by X inactivation at the blastocyst stage on Day 6.
Introduction
The measurement of enzyme activities in preimplantation embryos provides important information relating to changes in metabolism and gene expression at these early developmental stages. In the mouse, early cleavage-stage embryos consume pyruvate preferentially and only switch to the utiliz¬ ation of glucose at the blastocyst stage (Leese & Barton, 1984) . The activity profiles of several metabolic enzymes, including glucose 6-phosphate dehydrogenase (Leese, 1987) which catalyses the first reaction of the pentose phosphate pathway, have been established, giving insights into the control of alternative metabolic pathways.
Human preimplantation embryos also switch their energy substrate preference from pyruvate to glucose at the blastocyst stage (Hardy et ai, 1989) . Apart from some recent measurements of the activities of several enzymes in aged unfertilized oocytes (Chi et ai, 1988) and a small number of measurements of glucose phosphate isomerase activity in oocytes and embryos (West et ai, 1989) , however, little is known about the activity profiles of enzymes involved in metabolism at these stages. Preimplantation diagnosis of some inherited diseases affecting ubiquitously expressed enzymes may be possible by measuring altered activity in cells biopsied from embryos (Penketh & McLaren, 1987) . For example, deficiency of the X-linked enzyme hypoxanthine guanine phosphoribosyl transferase (HGPRT) causes Lesch-Nyhan syndrome, in which affected boys suffer from spastic cerebral palsy and compulsive self-mutilation and generally die in their teens (Lesch & Nyhan, 1964 Rutherford et al. (1988) . After pituitary-gonadal suppression with a luteinizing hormone-releasing hormone agonist (Buserelin, Hoechst, Hounslow, Middlesex, UK), patients were superovulated with human menopausa! gonadotrophin (Pergonal, Serono, Welwyn Garden City, Herts, UK). At 35 h before egg collection 10 000 i.u. human chorionic gonadotrophin (Pregnyl, Organon, Cambridge, UK) were given. Oocytes were collected, preincubated for about 6 h and inseminated (Day 0). At 15-18 h later the oocytes were checked for normal fertilization. Embryos were cultured in 1 ml medium containing 10% heat-inactivated maternal serum under a gas phase of 5% C02, 5% 02 and 90% N2. The medium was either T6 (Quinn el ai, 1982) The resulting 3 µ solution was taken up into a 5-µ capillary tube, the ends were sealed with Parafilm and the tube was incubated for 3 h at 37°C. At the end of the incubation, the contents of the capillary tube were expelled into 27 µ 25 mM-ammonium phosphate and the resulting 30 µ volume was analysed for inosine monophosphate (IMP) and adenine monophosphate (AMP) on a Kontron 400 series high-performance liquid chromatography (HPLC) apparatus (Kontron Instruments, Watford, Herts, UK) using a Hypersil 5 ODS (25 cm 2 mm) column (Shandon, Runcorn, Cheshire, UK). The eluant was 25 mM-ammonium phosphate pH 4-6 at a flow rate of 0-3 ml min-1. The eluant was passed through a variable wavelength scanning detector set at 254 nm. Using this system, IMP, AMP, hypoxanthine and adenine were readily separated (Fig. 1) Fig. 2 . HGPRT activity increased from 12-1 to 17-3 pmol/embryo/h between Days 2 and 4. Activity was slightly lower on Day 5 before falling sharply to 8 0 pmol/embryo/h on Day 6. By contrast, APRT activities were much lower, in the range 1-3-2-0 pmol/embryo/h on Days 2-5, before increasing to 2-5 pmol/embryo/h on Day 6. The ratio of HGPRT: APRT activities was in the range of 7-2-10-2 on Days 2-5 and decreased to 3-2 on Day 6. Since APRT activity was low and relatively constant compared with HGPRT, the pattern exhibited by the ratio of activities paralleled closely HGPRT activity itself.
Discussion
HGPRT and APRT activities have been assayed simultaneously in single normally fertilized human embryos between Days 2 and 6 in vitro by quantifying reaction products after separation by HPLC. The activity profiles of the two enzymes over this period showed marked differences (Fig.  2) . HPRT precipitation, separation and counting of labelled reaction products (Epstein, 1970; Monk, 1987) . However, enzyme levels were approximately 25-50% those reported here (HGPRT levels were 0-75-5-8 pmol/embryo/h and APRT levels 0-025-1-1 pmol/embryo/h) and individual values for HGPRT activity were very variable, although there appeared to be a gradual decline in aged unfertilized eggs and embryos at later stages.
One difference between this method and ours which may account for the discrepancy in enzyme levels is the concentration of the two substrates used in the reaction. The method developed by Monk (1987) and used by Braude et ai (1990) uses concentrations of hypoxanthine and adenine of 10 µ , compared to 50 µ in each case in our method. The Michaelis constants for the two enzymes are in the range of 8 µ for HGPRT and 1-4-2-7 µ for APRT (Banholzer & Grobner, 1983; Loffler & Grobner, 1983) . This indicates that, while the substrate concentrations used by Monk (1987) would allow APRT to proceed at near its maximal rate, the activity of HGPRT is likely to be substantially underestimated. Furthermore, in our hands, the reaction rate is not linear after 3 h and the long incubations (up to 20 h) used by Braude et ai (1990) in some assays may have led to underestimation of enzyme activity, possibly exacerbated by substrate depletion over this period.
These methodological differences may also partly account for the low activities reported pre¬ viously for single mouse embryos compared with our values for the human. For example, the highest values reported by Monk (1987) for HGPRT averaged about 2 pmol/embryo/h whereas in the present study, the average value for all the human embryos was 13-4 pmol/embryo/h. Similarly, average maximum values for APRT in single mouse embryos were 01 pmol/embryo/h compared with 2-5 pmol/embryo/h in the human. However, the larger volume of the human embryo and the greater metabolic activity of human compared to mouse embryos (Hardy et ai, 1989) (Epstein, 1970; Monk, 1987) , providing evidence for embryonic expression of the enzyme (West, 1990) . This was also demonstrated by comparing activities in embryos from XX and XO mothers which revealed that, for HGPRT, the transition from oocyteto embryo-coded enzyme activity occurs at the morula stage (Epstein, 1972; Monk & Harper, 1978) . At this stage, both X chromosomes are active in females, resulting in a bimodal distribution of the ratio of X-linked HGPRT and autosome-coded APRT in male and female embryos (Epstein et ai, 1978; Monk & Harper, 1978) . This allowed the sex of embryos to be accurately predicted by measuring the ratio of the two enzyme activities in single blastomeres disaggregated from 8-cell morulae and cultured for 12 h (Monk & Handyside, 1988) . Later, at the blastocyst stage, this bimodal distribution is lost, probably due to X inactivation in a majority of the cells (Monk & Harper, 1978) .
In human embryos, HGPRT activity did not show the dramatic increase at the blastocyst stage observed in the mouse, but did increase significantly between Days 2 and 4 (P < 0001) when embryonic gene expression is first detected (Tesarik, 1987; Tesarik et ai, 1988; Braude et ai, 1988 ). It may therefore be possible to diagnose HGPRT deficiency on Day 4 or 5. The subsequent decline in activity at the blastocyst stage on Day 6 may be due to X inactivation in female embryos. Loss of enzyme activity resulting from the early stages of degeneration in vitro is unlikely because of the corresponding increase in APRT activity assayed in the same extracts. If this is the case, both HGPRT-deficient and carrier female embryos could be diagnosed from trophectoderm biopsies in which the paternal X chromosome is selectively inactivated, as demonstrated in the mouse (Monk et ai, 1988 
